In a development that has sent shockwaves through the medical establishment and prompted a fresh wave of panic-buying at British chemists, Canada has somehow managed to produce a generic version of Ozempic, the diabetes drug that doubles as a celebrity weight-loss miracle and triples as a public health crisis in the United States. While our American cousins are currently staging a nationwide manhunt for a single remaining dose of the stuff, Canadians are apparently swimming in it, grinning politely, and offering it to their neighbours like free healthcare. Which, ironically, they already have.
The news broke this morning, sending British patients into a frenzy of righteous indignation. For years, they have endured the NHS’s glacial approval process, watching as Americans paid $1,600 a month for the privilege of losing a dress size while simultaneously bankrupting their grandchildren. Now, with Canada joining the generic party, the British public is demanding to know why they can’t have a piece of the action. “It’s not fair,” said one patient, whose name I have changed to protect the innocent and whose waistline I have not measured for legal reasons. “We’ve been told Ozempic is a miracle drug, but all we get is a pamphlet on ‘healthy eating’ and a link to a 2012 BBC article about Michael Mosley’s 5:2 diet.”
Let us not forget the sheer comedy of the American shortage. The US, a country that prides itself on being the best at everything except affordable healthcare, has been caught with its trousers down and its prescription pads empty. Meanwhile, Canada, the nation that brought us maple syrup and a surprisingly resilient monarchy, has somehow sidestepped the crisis by manufacturing a generic version. This is the equivalent of a Formula 1 car breaking down while a horse and cart trots past, waving a union jack and blowing a raspberry.
But the real victims here are the British people, who are watching this circus unfold from the sidelines. They have been gaslit by the pharmaceutical industry into believing that Ozempic is some kind of magical elixir, a modern-day snake oil that cures diabetes, obesity, and perhaps even existential dread. The demand for reform is reaching fever pitch. Campaign groups are forming. Disgruntled diabetics are sharpening their pitchforks and pointing them at Whitehall.
I say good. It is high time the British government stopped treating the NHS like a charity shop and started treating it like a national treasure that deserves proper funding. If Canada can churn out generic Ozempic like a Monty Python sketch involving a dead parrot and a health minister, then so can we. All it takes is a bit of political will, a lot of corporate teeth-gnashing, and the quiet realisation that public health is not a profit centre.
As for America, I suspect they will eventually solve their shortage by doing what they do best: throwing money at the problem until it goes away, then suing everyone involved for emotional distress. In the meantime, let us salute Canada for showing the world that generic drugs are not just a pipe dream. And let us hope the British government is taking notes, preferably on a prescription pad.
Now, if you will excuse me, I have a pressing appointment with a gin and tonic. My diabetes can wait.
